| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/12/2001 | CN1325854A Polypeptide-high-mobility component protein 10 and polynucleotide for coding it |
| 12/12/2001 | CN1325742A Polypeptide-tyrosine-specific protein phosphotase 13 and polynucleotide for coding it |
| 12/12/2001 | CN1076052C Nucleic acid sequences, carrier containing them, medical compositions and usage for treatment |
| 12/11/2001 | US6329575 Inbred maize line 2227BT |
| 12/11/2001 | US6329574 High lysine fertile transgenic corn plants |
| 12/11/2001 | US6329573 Plants containing the gdhA gene and methods of use thereof |
| 12/11/2001 | US6329572 Plant promoter activated by fungal infection |
| 12/11/2001 | US6329571 Transforming immature embryo cells of indica rice by agrobacterium tumefaciens and selecting transformed cells by using a drug for selection |
| 12/11/2001 | US6329570 Cotton modification using ovary-tissue transcriptional factors |
| 12/11/2001 | US6329568 Tospovirus resistance in plants |
| 12/11/2001 | US6329567 Methods for improving seeds |
| 12/11/2001 | US6329566 Methods for the detection, treatment, and prevention of neurodegeneration |
| 12/11/2001 | US6329518 Nucleic acid from crepis plant coding for enzyme that catalyzes epoxygenation of carbon double bond at delta-12 position of fatty acid; efficient production of coatings, glues, plastics, surfactants and lubricants |
| 12/11/2001 | US6329517 Dermatomyositis-specific auto-antigen |
| 12/11/2001 | US6329515 Includes bivalent metal cation, trivalent metal cation, and biomaterial such as nucleoside-5'-monophosphate, nucleoside-5'-triphosphate, dna or rna |
| 12/11/2001 | US6329511 Humanized mouse af2 immunoglobulin having specific amino acid sequences; treatment of autoimmune diseases |
| 12/11/2001 | US6329504 Antifungal polypeptide and methods for controlling plant pathogenic fungi |
| 12/11/2001 | US6329503 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 12/11/2001 | US6329501 Methods and compositions for targeting compounds to muscle |
| 12/11/2001 | US6329417 Hepatitis C inhibitor tri-pepitides |
| 12/11/2001 | US6329379 Oligopeptides for inhibiting hepatitis |
| 12/11/2001 | US6329348 Method of inducing angiogenesis |
| 12/11/2001 | US6329341 Method of treating septic shock |
| 12/11/2001 | US6329340 Human Defensin DEF-X |
| 12/11/2001 | US6329204 Plant caffeic acid 3-0-methyltransferase homologs |
| 12/11/2001 | US6329203 Antisense modulation of glioma-associated oncogene-1 expression |
| 12/11/2001 | US6329202 Antibodies directed against binding associated epitopes |
| 12/11/2001 | US6329201 An rna vector having alphavirus transcription sequences, a promoter and untranslated region from subgenomic venezuelan equine encephalitis, and alphavirus structural protein sequences; for directing expression of heterologous genes |
| 12/11/2001 | US6329200 Plasmids for construction of eukaryotic viral vectors |
| 12/11/2001 | US6329199 A vector resistant to inactivation by human serum, produced in cells containing retroviral envelope protein sequence from feline endogenous virus, long terminal repeats sequences, signal and packaging sequences; for effective gene therapy |
| 12/11/2001 | US6329198 Production and use of human nm23 protein and antibodies therefor |
| 12/11/2001 | US6329197 DNA encoding galanin GALR3 receptors and uses thereof |
| 12/11/2001 | US6329191 DNA encoding recombinant coffee bean alpha-galactosidase |
| 12/11/2001 | US6329190 Targetting adenovirus with use of constrained peptide motifs |
| 12/11/2001 | US6329187 Endoglucanases |
| 12/11/2001 | US6329185 A polypeptide from a basidiomycota fungus; for preparing mono-component galactanase composition; for use as bulking agents, preparation of fruit or vegetable juices, regulate consistency and appearance of processed fruits or vegetables |
| 12/11/2001 | US6329183 Providing diols which can be converted into 3-hydroxypropionate or 3-hydroxyvalerate monomers by enzymes expressed by organisms; culturing organisms to produce polyhydroxyalkanoates |
| 12/11/2001 | US6329181 A genetically engineered nucleic acid derived from parvovirus virions with a reduced number of replication competent particles; gene therapy |
| 12/11/2001 | US6329178 A mutant polymerase having asptyrserglnilegluleuarg amino acid sequence in the active site and possesses altered fidelity or altered catalytic activity |
| 12/11/2001 | US6329177 Providing primer ligating the 3' end of the carrier molecule to the 5' position of the primer with rna ligase; thereby obtaining a ligation product; deprotecting the ligation product by removing purine or pyrimidine ribonucleoside |
| 12/11/2001 | US6329176 Culturing mammals cells containing a nucleic acid sequence that codes a saccharomyces endoprotease, in a serum free medium and isolating the protein from the medium |
| 12/11/2001 | US6329174 A nucleic acid isolated from heliothis; insecticides |
| 12/11/2001 | US6329173 Method of intracellular binding target molecules |
| 12/11/2001 | US6329172 An isolated atp binding cassette transporter gene from psedomonas fluorescens for enhanced secretion of foreign proteins produced and accumulated in extracellular medium; for use in medicaments, biochemical synthesis, food additives |
| 12/11/2001 | US6329171 23484, A novel human ubiquitin protease |
| 12/11/2001 | US6329160 A construct with nucleic acid molecule encoding a reporter molecule, a second molecule encoding an enzyme that produces a substrate for the reporter molecule; both being controlled by separate inducible promoter; for environmental monitoring |
| 12/11/2001 | US6329159 An antibody or antigen binding fragment which binds mammalian chemokine receptor and inhibits the binding of ligand to the receptor; therapy and diagnosis of inflammatory disease associated with mucosal tissues |
| 12/11/2001 | US6329150 Amplifying target circles by rolling circle replication of circular nucleic acids; detect amplified sequences using combinatorial multicolor coding probes for quantitative detection of multiple different amplified target circles |
| 12/11/2001 | US6329146 Mass spectrometric methods for biomolecular screening |
| 12/11/2001 | US6329144 Probe for analysis of target nucleic acids |
| 12/11/2001 | US6329142 Assay of nucleic acid by fluorescence polarization technique and detection of verotoxin-producing microorganisms |
| 12/11/2001 | US6329141 Genetically engineered dna that when transformed in phaffia rhodozyme is highly expressed in the glycolytic pathway coding for glyceraldehye-3-phosphate dehydrogenase or a ribosomal protein encoding gene |
| 12/11/2001 | US6329140 Screening clones on a support that is a high-density nucleic acid array by analyzing hybridization of a target nucleic acid with differently sequenced polynucleotide probes using various stringency conditions |
| 12/11/2001 | US6329138 Method for detection of the antibiotic resistance spectrum of mycobacterium species |
| 12/11/2001 | US6329137 Intact cell assay for protein tyrosine phosphatases using recombinant baculoviruses |
| 12/11/2001 | US6328975 Recombinant swinepox virus |
| 12/11/2001 | US6328974 Immunogenic compositions that potentiate growth hormone activity |
| 12/11/2001 | US6328973 Method of raising neutralizing antibodies against HIV |
| 12/11/2001 | US6328971 MAGE-1 derived nona peptides, and compositions thereof |
| 12/11/2001 | US6328970 Rapamycin position 27 conjugates |
| 12/11/2001 | US6328968 Organ transplant |
| 12/11/2001 | US6328963 For purifying or assaying human mp52 produced b genetic engineering techniques |
| 12/11/2001 | US6328962 Conjugate molecules are produced by genetic modification of genes encoding light and heavy chains of the surface structure specific antibody and expression in mammal cells to produce the conjugated antibody; enhanced immune response |
| 12/11/2001 | US6328958 Deleted adenovirus vectors and methods of making and administering the same |
| 12/11/2001 | US6328957 Heat shock proteins and the treatment of tumors |
| 12/11/2001 | CA2329482C Recombinant antibodies specific for tnf-.alpha. |
| 12/11/2001 | CA2281956C A novel protease |
| 12/11/2001 | CA2205057C Device and method for dna amplification and assay |
| 12/11/2001 | CA2162132C Hepatitis b virus mutants, reagents and methods for detection |
| 12/11/2001 | CA2136429C Combined vaccines comprising hepatitis b surface antigen and other antigens |
| 12/11/2001 | CA2136094C Methods and compositions for increasing the sensitivity of a cell to a dna damaging agent |
| 12/11/2001 | CA2117953C Human stromal derived factor 1 alpha and 1 beta and dnas encoding the same |
| 12/11/2001 | CA2090614C 5' to 3' exonuclease mutations of thermostable dna polymerases |
| 12/11/2001 | CA2066053C Recombinant retroviruses delivering vector constructs to target cells |
| 12/11/2001 | CA2065874C Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer |
| 12/11/2001 | CA2050477C T cell growth factor |
| 12/11/2001 | CA2022487C Optimized fermentation processes for the preparation of foreign proteins in e.coli |
| 12/09/2001 | CA2309379A1 Viral variants and uses therefor |
| 12/08/2001 | CA2345979A1 Probes and methods for detection of nucleic acids |
| 12/06/2001 | WO2001092990A2 Structure-based methods for assessing amino acid variances |
| 12/06/2001 | WO2001092891A2 Regulating lipid levels via the zmax1 or hbm gene |
| 12/06/2001 | WO2001092883A2 Surface for the immobilisation of ligands |
| 12/06/2001 | WO2001092877A2 Method of identifying and/or isolating stem cells |
| 12/06/2001 | WO2001092876A2 Method for identifying compounds for modulating the activity of a tumour suppressor protein |
| 12/06/2001 | WO2001092584A1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 12/06/2001 | WO2001092583A1 Determination of nucleotide sequence variations through limited primer extension |
| 12/06/2001 | WO2001092581A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 12/06/2001 | WO2001092580A2 Lyophilizable and enhanced compacted nucleic acids |
| 12/06/2001 | WO2001092579A2 Methods for detecting target nucleic acids using coupled ligation and amplification |
| 12/06/2001 | WO2001092578A2 Reagents and methods for identifying and modulating expression of genes regulated by retinoids |
| 12/06/2001 | WO2001092577A1 Extracellular drug-oligonucleotides chimeric molecules |
| 12/06/2001 | WO2001092573A1 Diagnosis kit for mycobacterium species identification and drug-resistance detection and manufacturing method thereof |
| 12/06/2001 | WO2001092567A2 Novel target genes for diseases of the heart |
| 12/06/2001 | WO2001092566A2 Immobilized nucleic acids and uses thereof |
| 12/06/2001 | WO2001092565A2 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
| 12/06/2001 | WO2001092556A1 A process for the fermentative preparation of d-pantothenic acid using coryneform bacteria with deleted pck (phosphoenolpyruvate carboxykinase, 4.1.1.49) gene |
| 12/06/2001 | WO2001092552A2 Method for the purification of alphavirus replicon particles |
| 12/06/2001 | WO2001092551A2 Duplexed parvovirus vectors |
| 12/06/2001 | WO2001092550A2 Methods and compositions for efficient gene transfer using transcomplementary vectors |
| 12/06/2001 | WO2001092549A2 Method and composition for targeting an adenoviral vector |